- Ribavirin has two FDA “black box” warnings :
Use before or during pregnancy by either sex may result in birth defects in the baby.
Risk of red blood cell breakdown.
- Ribavirin should not be given with Zidovudine (AZT) because of the increased risk of Anemia
- Ribavirin should not be given with Didanosine because of the increased risk of Mitochondrial toxicity
Please refer to the manufacturer’s website for all this medicine’s information